We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
-18.58%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$736M
AUM Growth
-$206M
Cap. Flow
-$15M
Cap. Flow %
-2.04%
Top 10 Hldgs %
41.67%
Holding
172
New
4
Increased
40
Reduced
22
Closed
68

Sector Composition

Rank Sector Weight
1 Healthcare 81.78%
2 Technology 1.41%
3 Industrials 1.2%
4 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MGTX icon
51
MeiraGTx Holdings
MGTX
$1.08B
$3.93M 0.53%
407,906
ASMB icon
52
Assembly Biosciences
ASMB
$498M
$3.56M 0.48%
+13,117
New +$3.79M
SAGE
53
DELISTED
Sage Therapeutics
SAGE
$3.55M 0.48%
37,100
MDGL icon
54
Madrigal Pharmaceuticals
MDGL
$12.6B
$3.21M 0.44%
28,487
+2,600
+10% +$402K
CSII
55
DELISTED
Cardiovascular Systems, Inc.
CSII
$2.87M 0.39%
+100,862
New +$3.2M
NITE
56
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
$2.69M 0.37%
233,711
-4,545
-2% -$60.5K
FSTX
57
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$2.62M 0.36%
62,914
-10,000
-14% -$450K
JNJ icon
58
Johnson & Johnson
JNJ
$640B
$2.3M 0.31%
17,799
-121,481
-87% -$16.9M
ONC
59
BeOne Medicines Ltd
ONC
$33.9B
$2.09M 0.28%
14,927
+5,000
+50% +$663K
MTEM
60
DELISTED
Molecular Templates, Inc.
MTEM
$1.41M 0.19%
23,333
ALDR
61
DELISTED
Alder Biopharmaceuticals
ALDR
$1.31M 0.18%
128,300
-481,312
-79% -$6.16M
TMO icon
62
Thermo Fisher Scientific
TMO
$214B
$1.02M 0.14%
4,549
ELV icon
63
Elevance Health
ELV
$81.5B
$883K 0.12%
3,361
-30
-0.9% -$8.25K
HCM icon
64
HUTCHMED
HCM
$1.96B
$730K 0.1%
31,628
RDY icon
65
Dr. Reddy's Laboratories
RDY
$9.8B
$682K 0.09%
90,485
-17,500
-16% -$123K
BDX icon
66
Becton Dickinson
BDX
$46.4B
$679K 0.09%
3,090
HCA icon
67
HCA Healthcare
HCA
$90.6B
$662K 0.09%
5,316
+30
+0.6% +$4.03K
IMGN
68
DELISTED
Immunogen Inc
IMGN
$650K 0.09%
135,313
+114,300
+544% +$694K
HUM icon
69
Humana
HUM
$43.9B
$526K 0.07%
1,836
+887
+93% +$281K
RARE icon
70
Ultragenyx Pharmaceutical
RARE
$2.46B
$393K 0.05%
9,047
STML
71
DELISTED
Stemline Therapeutics, Inc.
STML
$369K 0.05%
38,838
+20,300
+110% +$263K
HMSY
72
DELISTED
HMS Holdings Corp.
HMSY
$349K 0.05%
12,397
+90
+0.7% +$2.91K
KALV
73
DELISTED
KalVista Pharmaceuticals
KALV
$347K 0.05%
17,551
SRRA
74
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$343K 0.05%
5,042
UHS icon
75
Universal Health Services
UHS
$10.2B
$338K 0.05%
2,896
+85
+3% +$10.7K

Similar funds

Sectoral Asset Management's Q4 2018 Portfolio in Review

As of Q4 2018, Sectoral Asset Management held 172 positions worth $736M, down 22% from $942M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Sectoral Asset Management's Q4 2018 filing shows 4 new, 40 increased, 22 reduced and 68 closed positions. Its largest new stake was Kineta, Inc. Common Stock: 11,298 shares worth $5.13M. The largest sale was K2M Group Holdings, Inc, an estimated $24.8M.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, down from 85% a quarter earlier, followed by Technology and Industrials.

  • Sectoral Asset Management's largest Q4 2018 buy was Kineta, Inc. Common Stock: 11,298 shares worth $5.13M.
  • Sectoral Asset Management added most to Teladoc Health in Q4 2018, an estimated $19.6M increase.
  • Sectoral Asset Management's biggest Q4 2018 reduction was Johnson & Johnson, cutting an estimated $16.9M.
  • Sectoral Asset Management fully exited K2M Group Holdings, Inc in Q4 2018, selling an estimated $24.8M.
  • Sectoral Asset Management's ten largest holdings make up 42% of its $736M portfolio in Q4 2018.
  • Sectoral Asset Management opened 4 new positions and closed 68 in Q4 2018.
  • Sectoral Asset Management's portfolio value fell 22% quarter-over-quarter to $736M.

Based on Sectoral Asset Management's 13F filing for Q4 2018, filed 12 Feb 2019.